Our intellectual property allows Vector Vitale to play a unique role in the proper adjustment of a wide range of existing pharmaceutical products and in multiple food supplements as well as in the creation of a new generation of products combining the most efficient delivery systems for materials with specific isotope signatures. We believe that it represents a de facto new standard in the pharmaceutical industry.

Initial product targets include:
1. VV-Zn-64
Purified zinc sulfate and zinc citrate for IV and oral administration with 99.8% of Zn – 64
General anti-degenerative disease action

2. VV-K-39
IV and oral medicine with anti-metastases effect to be used prior and after surgical tumor removal procedures

3. VV-K-39/Zn-64
IV and oral medicine for treatment of various blood cancers and solid malignant tumors

4. VV-K-39-Zn-64-Mg-25
IV and oral medicine to prevent local and general ageing and strengthen immune system.

5. New anti-viral and anti-bacterial isotope selective formulations initially focused to fight hepatitis C, Herpes type 1 and type 2 and Staphylococcus aureus.

We are also developing new a isotope selective line:

6. VV- food supplements

7. VV- dietary products

8. VV- cosmetics

© Copyright 2015 - Vector Vitale